12-O-tetradecanoylphorbol-13-acetate (TPA) inhibits osteoclastogenesis by suppressing RANKL-induced NF-kappaB activation.
about
Prevention of wear particle-induced osteolysis by a novel V-ATPase inhibitor saliphenylhalamide through inhibition of osteoclast bone resorptionSinomenine suppresses osteoclast formation and Mycobacterium tuberculosis H37Ra-induced bone loss by modulating RANKL signaling pathwaysDisulfiram attenuates osteoclast differentiation in vitro: a potential antiresorptive agentMutations within the TNF-like core domain of RANKL impair osteoclast differentiation and activationPhenolic fraction of tobacco smoke condensate potentiates benzo[a]pyerene diol epoxide-induced cell transformation: role of protein kinase C.A formyl peptide receptor agonist suppresses inflammation and bone damage in arthritisLoss of protein kinase C-δ protects against LPS-induced osteolysis owing to an intrinsic defect in osteoclastic bone resorptionThe role of small molecules in bone regeneration.Macrophage migration inhibitory factor is essential for osteoclastogenic mechanisms in vitro and in vivo mouse model of arthritis.p62 ubiquitin binding-associated domain mediated the receptor activator of nuclear factor-kappaB ligand-induced osteoclast formation: a new insight into the pathogenesis of Paget's disease of bone.A genetic predictive model for canine hip dysplasia: integration of Genome Wide Association Study (GWAS) and candidate gene approaches.Protein kinase C delta null mice exhibit structural alterations in articular surface, intra-articular and subchondral compartments.Natural Germacrane Sesquiterpenes Inhibit Osteoclast Formation, Bone Resorption, RANKL-Induced NF-κB Activation, and IκBα Degradation.Berberine Sulfate Attenuates Osteoclast Differentiation through RANKL Induced NF-κB and NFAT Pathways.Andrographolide Inhibits Ovariectomy-Induced Bone Loss via the Suppression of RANKL Signaling Pathways.Cytoplasmic hnRNPK interacts with GSK3β and is essential for the osteoclast differentiation.Dihydroartemisinin prevents breast cancer-induced osteolysis via inhibiting both breast caner cells and osteoclasts.Amyloid β Peptide Enhances RANKL-Induced Osteoclast Activation through NF-κB, ERK, and Calcium Oscillation Signaling.Nitidine chloride prevents OVX-induced bone loss via suppressing NFATc1-mediated osteoclast differentiation.Bajijiasu Abrogates Osteoclast Differentiation via the Suppression of RANKL Signaling Pathways through NF-κB and NFAT.Andrographolide suppresses RANKL-induced osteoclastogenesis in vitro and prevents inflammatory bone loss in vivo.Protein kinase C inhibitor, GF109203X attenuates osteoclastogenesis, bone resorption and RANKL-induced NF-κB and NFAT activity.Andrographolide prevents human breast cancer-induced osteoclastic bone loss via attenuated RANKL signaling.Comparison of the cytotoxic and inflammatory responses of titanium particles with different methods for endotoxin removal in RAW264.7 macrophages.Paclitaxel inhibits osteoclast formation and bone resorption via influencing mitotic cell cycle arrest and RANKL-induced activation of NF-κB and ERK.Naringin abrogates osteoclastogenesis and bone resorption via the inhibition of RANKL-induced NF-κB and ERK activation.Serum calcium-decreasing factor, caldecrin, inhibits osteoclast differentiation by suppression of NFATc1 activity.Caffeic acid phenethyl ester, an active component of honeybee propolis attenuates osteoclastogenesis and bone resorption via the suppression of RANKL-induced NF-kappaB and NFAT activity.Myocyte enhancer factor 2 and microphthalmia-associated transcription factor cooperate with NFATc1 to transactivate the V-ATPase d2 promoter during RANKL-induced osteoclastogenesis.Eriodictyol Inhibits RANKL-Induced Osteoclast Formation and Function Via Inhibition of NFATc1 Activity.Luteoloside prevents lipopolysaccharide-induced osteolysis and suppresses RANKL-induced osteoclastogenesis through attenuating RANKL signaling cascades.Mangiferin attenuates osteoclastogenesis, bone resorption, and RANKL-induced activation of NF-κB and ERK.Thapsigargin modulates osteoclastogenesis through the regulation of RANKL-induced signaling pathways and reactive oxygen species production.Cyanidin Chloride inhibits ovariectomy-induced osteoporosis by suppressing RANKL-mediated osteoclastogenesis and associated signaling pathways.DGKζ Downregulation Enhances Osteoclast Differentiation and Bone Resorption Activity Under Inflammatory Conditions.Identification and analysis of function of a novel splicing variant of mouse receptor activator of NF-κB.Paeoniflorin regulates osteoclastogenesis and osteoblastogenesis via manipulating NF-κB signaling pathway both in vitro and in vivo.
P2860
Q28482246-CE9648A8-B433-49DF-B2B9-390D95039688Q28533497-F58E0743-5581-456B-BE46-2E43E46EF307Q28546890-8C731D4B-9E73-4B6B-81F6-13AAFF9E82F2Q33642546-5325FFC3-3764-4C8B-B1A8-5BCA9193AD3CQ33701466-EF041344-7B33-4C6A-9FDB-FA47A715819DQ34571412-6390424C-71EC-4BCC-98F9-E19B23C14643Q34947739-67251172-D35C-4551-A95D-158B00A36A79Q34991901-78E27D7A-FC53-4EF0-AF3D-DA85377A9847Q35163701-88938427-F535-41B1-9D36-CCB4C32245FCQ35221973-EF1820AF-69C8-40AE-B5D4-DB7EE5D6EEDCQ35390459-75125142-4B2F-4478-9E37-07143FE53BF1Q35962168-37AF34CC-A27B-466C-BB9B-9E8D4E012A4EQ36324551-E29873E7-975E-4F89-939F-4E5E9BF65780Q36324625-CF2C7153-5529-41B9-A22B-3A24CB4409D2Q36324729-2365249B-4DA3-468F-B572-EF29BAC4C47CQ36350166-C044FBB6-5FAD-415D-BBB5-1A938D6344F1Q36442668-784F5439-4C7D-4358-AD5B-E1571636E577Q37377385-49FAA44E-DF06-4931-8293-C9164FC95CBFQ37399717-119492DA-FE0C-445C-B581-048CE1243CB1Q37631691-9DB04E1F-4CC2-47B3-ACD4-E4C4071F3FCBQ37671291-AE082A54-C50E-45C3-8F85-B81BF7A96503Q38943284-7C1FA909-5B1C-49B2-AD7F-B332068921D5Q39028702-2A4B0488-CE25-46E3-A84E-D933F54B0AF4Q39391743-FF2BE9B4-0160-489E-A415-D00054B427CEQ39451512-0136B7DD-9F0E-4C0B-B02B-52AD254ED376Q39491637-3DE1352A-EF6A-4317-AE5A-0AC2EE2D9446Q39693083-0B5DC560-DD2C-4680-B3AE-E184CC155AA0Q39812715-68D0D6C7-D928-42CB-A8FB-98EBABF05085Q39868307-5F3E62F3-8F26-402D-ABCB-918052CB4697Q40120415-E326C4E1-A42F-4C2E-8220-93D09E2D1383Q40145765-EC443893-E063-40DB-A3F7-4A3EBA77C20FQ42947280-6FEF5DBE-6668-4F6A-B140-B40F1993BC5FQ46592953-46623D50-BE14-4F08-AEA3-99D72F49C989Q47995224-FFA1883F-AC8D-49C7-8764-FBD0FADFC224Q51698912-68E9388B-64A6-4679-99CB-C0C0CA07C90BQ53283430-0FFA4A3C-030A-41D3-8B32-94C67F4FB365Q55344415-A638C7CE-50E9-4D5B-860B-AC1C9A77BD97
P2860
12-O-tetradecanoylphorbol-13-acetate (TPA) inhibits osteoclastogenesis by suppressing RANKL-induced NF-kappaB activation.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
12-O-tetradecanoylphorbol-13-a ...... -induced NF-kappaB activation.
@en
type
label
12-O-tetradecanoylphorbol-13-a ...... -induced NF-kappaB activation.
@en
prefLabel
12-O-tetradecanoylphorbol-13-a ...... -induced NF-kappaB activation.
@en
P2093
P2860
P1476
12-O-tetradecanoylphorbol-13-a ...... -induced NF-kappaB activation.
@en
P2093
Cathy Wang
David A Joyce
James H Steer
Kirk H M Yip
Ming H Zheng
P2860
P304
P356
10.1359/JBMR.2003.18.12.2159
P577
2003-12-01T00:00:00Z